The cyclophilin inhibitor Debio-025 is a potent inhibitor of hepatitis C virus replication in vitro with a unique resistance profile

被引：7
|
作者：
Coelmont, Lotte
Paeshuyse, Jan
Kaptein, Suzanne
Vliegen, Inge
Kaul, Artur
De Clercq, Erik
Rosenwirth, Brigitte
Scalfaro, Pietro
Crabbe, Raf
Bartenschlager, Ralf
Dumont, Jean-Maurice
Neyts, Johan
机构：
[1] Katholieke Univ Leuven, Rega Inst, Louvain, Belgium
[2] Univ Heidelberg, Heidelberg, Germany
[3] Debiopharm, Lausanne, Switzerland
[4] Med Univ Wien, Vienna, Austria
来源：
ANTIVIRAL RESEARCH | 2007年 / 74卷 / 03期
关键词：
D O I：
10.1016/j.antiviral.2007.01.037
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
29
引用
收藏
页码：A39 / A39
页数：1
相关论文
共 50 条
  • [21] In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A
    Asante-Appiah, Ernest
    Liu, Rong
    Curry, Stephanie
    McMonagle, Patricia
    Agrawal, Sony
    Carr, Donna
    Rokosz, Laura
    Lahser, Frederick
    Bystol, Karin
    Chase, Robert
    Black, Stuart
    Ferrari, Eric
    Ingravallo, Paul
    Tong, Ling
    Yu, Wensheng
    Kozlowski, Joseph
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (11)
  • [22] The Cyclophilin Inhibitor Debio 025 Combined with PEG IFNα2a Significantly Reduces Viral Load in Treatment-Naive Hepatitis C Patients
    Flisiak, Robert
    Feinman, Saya V.
    Jablkowski, Maciej
    Horban, Andrzej
    Kryczka, Wieslaw
    Pawlowska, Malgorzata
    Heathcote, Jenny E.
    Mazzella, Giuseppe
    Vandelli, Carmen
    Nicolas-Metral, Valerie
    Grosgurin, Pierre
    Liz, Jorge S.
    Scalfaro, Pietro
    Porchet, Herve
    Crabbe, Raf
    HEPATOLOGY, 2009, 49 (05) : 1460 - 1468
  • [23] A nucleoside inhibitor of hepatitis C virus replication efficiently inhibits the replication of flaviviruses in vitro
    Leyssen, P
    De Lamballerie, X
    De Clercq, E
    Neyts, J
    ANTIVIRAL RESEARCH, 2006, 70 (01) : A80 - A80
  • [24] In Vitro Resistance Profile of the Hepatitis C Virus NS3 Protease Inhibitor BI 201335
    Lagace, Lisette
    White, Peter W.
    Bousquet, Christiane
    Dansereau, Nathalie
    Do, Florence
    Llinas-Brunet, Montse
    Marquis, Martin
    Massariol, Marie-Josee
    Maurice, Roger
    Spickler, Catherine
    Thibeault, Diane
    Triki, Ibtissem
    Zhao, Songping
    Kukolj, George
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (01) : 569 - 572
  • [25] NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon
    Ma, Sue
    Boerner, Joanna E.
    TiongYip, ChoiLai
    Weidmann, Beat
    Ryder, Neil S.
    Cooreman, Michael P.
    Lin, Kai
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) : 2976 - 2982
  • [26] Hydroxyurea as an inhibitor of hepatitis C virus RNA replication
    Akito Nozaki
    Manabu Morimoto
    Masaaki Kondo
    Takashi Oshima
    Kazushi Numata
    Shin Fujisawa
    Takeshi Kaneko
    Eiji Miyajima
    Satoshi Morita
    Kyoko Mori
    Masanori Ikeda
    Nobuyuki Kato
    Katsuaki Tanaka
    Archives of Virology, 2010, 155 : 601 - 605
  • [27] Hydroxyurea as an inhibitor of hepatitis C virus RNA replication
    Nozaki, Akito
    Morimoto, Manabu
    Kondo, Masaaki
    Oshima, Takashi
    Numata, Kazushi
    Fujisawa, Shin
    Kaneko, Takeshi
    Miyajima, Eiji
    Morita, Satoshi
    Mori, Kyoko
    Ikeda, Masanori
    Kato, Nobuyuki
    Tanaka, Katsuaki
    ARCHIVES OF VIROLOGY, 2010, 155 (04) : 601 - 605
  • [28] Phosphorothioate oligonucleotide is a potent entry inhibitor of hepatitis C virus infection in vitro and in vivo
    Matsumura, Takuya
    Kato, Takanobu
    Hu, Zongyi
    Imamura, Michio
    Hiraga, Nobuhiko
    Juteau, Jean-Marc
    Vaillant, Andrew
    Chayama, Kazuaki
    Liang, T. Jake
    HEPATOLOGY, 2007, 46 (04) : 852A - 852A
  • [29] In Vitro Antiviral Activity and Resistance Profile Characterization of the Hepatitis C Virus NS5A Inhibitor Ledipasvir
    Cheng, Guofeng
    Tian, Yang
    Doehle, Brian
    Peng, Betty
    Corsa, Amoreena
    Lee, Yu-Jen
    Gong, Ruoyu
    Yu, Mei
    Han, Bin
    Xu, Simin
    Dvory-Sobol, Hadas
    Perron, Michel
    Xu, Yili
    Mo, Hongmei
    Pagratis, Nikos
    Link, John O.
    Delaney, William
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1847 - 1853
  • [30] In Vitro and In Vivo Antiviral Activity and Resistance Profile of Ombitasvir, an Inhibitor of Hepatitis C Virus NS5A
    Krishnan, Preethi
    Beyer, Jill
    Mistry, Neeta
    Koev, Gennadiy
    Reisch, Thomas
    DeGoey, David
    Kati, Warren
    Campbell, Andrew
    Williams, Laura
    Xie, Wangang
    Setze, Carolyn
    Molla, Akhteruzzaman
    Collins, Christine
    Pilot-Matias, Tami
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (02) : 979 - 987
12345